Shah Amit B.
CFO
Shah Amit B. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.
On the most recent filing, Shah Amit B. is listed as CFO at Oncotelic Therapeutics, Inc. Inside the rolling window, Shah Amit B. reported 1 open-market purchase totaling $1K in OTLC and no open-market sales.
Companies traded
Other insiders at OTLC
Insider Buying
$1K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shah Amit B. made?
Shah Amit B. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Shah Amit B. trade?
Shah Amit B. has filed SEC Form 4 disclosures for 1 company, including OTLC.
When was Shah Amit B.'s most recent SEC Form 4 filing?
Shah Amit B.'s most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.
What is Shah Amit B.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shah Amit B. is listed as CFO.
What is Shah Amit B.'s total buy and sell value in the current window?
Inside the rolling retention window, Shah Amit B. bought $1K and sold $0 based on SEC Form 4 filings.
What was Shah Amit B.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 20,000 OTLC shares on 2026-06-22, worth $1K, per SEC Form 4 filings.